Citrini Bets on Life Sciences After Claude AI Drug Study

Bloomberg
Read the full article
Citrini Research highlights the potential benefits for life sciences companies from AI-driven drug discovery after evaluating Anthropic PBC's Claude Science model. The study underscores AI's growing role in advancing pharmaceutical research.

More in Healthcare

Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)
Healthcare5 min read

Microsoft says its AI tool is better than doctors at diagnosing conditions

Covered by 5 sources